Study Title

SPECT Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m DB8 ([99mTc]Tc- DB8) in Prostate Cancer and Breast Cancer Patients

Study Details

Description:

The study should evaluate the biological distribution of 99mTc-DB8 in patients with prostate cancer and breast cancer. The primary objective are: To assess the distribution of [99mTc]Tc- DB8 in normal tissues and tumors at different time intervals. To evaluate dosimetry of [99mTc]Tc- DB8. To study the safety and tolerability of the drug [99mTc]Tc- DB8 after a single injection in a diagnostic dosage. The secondary objective are: 1. To compare the obtained [99mTc]Tc- DB8 SPECT imaging results with the data of CT and/or MRI and/or ultrasound examination and immunohistochemical (IHC) studies in prostate cancer and breast cancer patients.

Sponsor:

Tomsk National Research Medical Center of the Russian Academy of Sciences

Contacts:

Vladimir I Chernov, MD,Prof

chernov@tnimc.ru

+73822426284

Anastasiy N Rybina, MD,PhD

pankovaan@mail.ru

+73822426284

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468